✦ LIBER ✦

PTEN, PIK3CA, p-AKT, and p-p70S6K Status: Association with Trastuzumab Response and Survival in Patients with HER2-Positive Metastatic Breast Cancer

✍ Scribed by Francisco J. Esteva; Hua Guo; Siyuan Zhang; Cesar Santa-Maria; Steven Stone; Jerry S. Lanchbury; Aysegul A. Sahin; Gabriel N. Hortobagyi; Dihua Yu

Book ID: 119980970
Publisher: American Society for Investigative Pathology
Year: 2010
Tongue: English
Weight: 455 KB
Volume: 177
Category: Article
ISSN: 0002-9440
DOI: 10.2353/ajpath.2010.090885

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of p95HER2 overexp

Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

✍ Tural, D; Serdengecti, S; Demirelli, F; Öztürk, T; İlvan, S; Turna, H; Özgüroglu 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 894 KB

2128 POSTER PTEN, EGFR, MAPK and Akt sta

2128 POSTER PTEN, EGFR, MAPK and Akt status by immunohistochemistry (IHC) in HER2-positive (HER2+) metastatic breast cancer (MBC) patients (pts) treated with trastuzumab (T) ± chemotherapy (CT): correlation with clinical outcome

✍ S. Gori; V. De Angelis; A. Sidoni; M. Colozza; I. Ferri; D. Fenocchio; V. Ludovi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Evaluation of the association of PIK3CA

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

✍ E. Razis; M. Bobos; V. Kotoula; A. G. Eleftheraki; H. P. Kalofonos; K. Pavlakis; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 288 KB

KI67 and p53 are not predictive of tumor

KI67 and p53 are not predictive of tumor response or survival with trastuzumab-based therapy in metastatic breast cancer patients (pts) with her2/neu-overexpression

✍ A. Schneeweiss; F. Lenz; F. Beldermann; M. Geberth; R. Goerner; P. Sinn; H.-J. S 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Biodistribution of 89Zr-trastuzumab and

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

✍ Dijkers, E C; Oude Munnink, T H; Kosterink, J G; Brouwers, A H; Jager, P L; de J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 309 KB

490 Long term survival and incidence of

490 Long term survival and incidence of brain metastasis in HER2- positive (HER2+) metastatic breast cancer patients (MBC) treated with trastuzumab (T): an institutional based review

✍ V. Diéras; M.N. Guilhaume; M. Fall; J.Y. Pierga; P. Beuzeboc; P. Cottu; C. Simon 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB